ScripCapstan Therapeutics Inc. and Engrail Therapeutics are among the latest companies to raise venture capital mega-rounds of $100m or more as the deluge of large private financings early in 2024 coinc
ScripZydus Cadila ’s application to the Indian regulator for an accelerated nod or emergency use authorization (EUA) for its COVID-19 vaccine takes the world a step closer to the first plasmid DNA vaccine